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Percutaneous endomyocardial biopsy (right ventricle in
10, left ventricle in 2) was performed in 12patients, aged
9 to 57 years, with serious ventricular arrhythmias oc-
curring in the setting of normal cardiac anatomy and
mechanical function. Light microscopic examination of
tissue revealed histologic abnormalities in 11 patients,
including myocardial cellular hypertrophy in 7, inter-
stitial fibrosis in 5, endocardial fibrosis in 2, myocardial
Although the majority of patients with serious ventricular
arrhythmias, including sudden cardiac arrest, have overt
cardiac anatomic abnormalities (1-5), previous studies (1-21)
have shown that no cause can be identified in up to 10% of
these patients, who are said to have primary electrical dis-
ease (17,19,20). The diagnostic value of endomyocardial
biopsy in patients with primary electrical heart disease has
not been discussed to our knowledge. We postulated that
ventricular tachycardia or fibrillation might be the initial
presentation in patients with subclinical heart disease and
that endomyocardial biopsy might be useful in diagnosis
and management.
This report documents our experience with endomy-
ocardial biopsy in 12 patients with ventricular tachycardia
or fibrillation in whom no identifiable cardiac abnormality
was found before biopsy.
Methods
Clinical features (Table 1). Between September 1979
and August 1983, endomyocardial biopsy was performed
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degenerative changes in 1 and increased interstitial cel-
lularity in 1. One patient had histologic evidence of acute
lymphocytic myocarditis. Thus, a majority of patients
with serious ventricular arrhythmias and normal cardiac
anatomy had histologic abnormalities, bringing into
question the concept of primary electrical heart disease
or idiopathic ventricular tachycardia.
in 12 patients (6 male and 6 female) with idiopathic ven-
tricular tachycardia or fibrillation in whom prior diagnostic
evaluation had revealed no cardiac anatomic abnormality.
The mean age was 34 years (range 9 to 57). Of the 10
patients who were symptomatic, 5 had one or more episodes
of presyncope, 3 had syncope and I who had been resus-
citated from an out of hospital cardiac arrest had documented
ventricular fibrillation. One or more episodes of ventricular
tachycardia or fibrillation had been documented clinically
in II patients. In 4 of the 11, ventricular tachycardia was
sustained (::2: 30 beats) and in 6 it was nonsustained (5 to
25 beats); the remaining patient had a history of syncope
and had sustained ventricular tachycardia induced by pro-
grammed ventricular stimulation.
The results ofdiagnostic evaluation, which included full
physical examination, chest roentgenogram, 12 lead elec-
trocardiogram, vectorcardiogram and two-dimensional
echocardiogram, were normal in all patients. Seven patients
underwent a treadmill exercise stress test and all results were
negative for ischemic changes. Exercise-induced arrhyth-
mias occurred during or immediately after the test in six
patients: ventricular tachycardia in four, paroxysmal supra-
ventricular tachycardia in one and complex ventricular ec-
topic rhythm (Lown grade 4B) in one. Left ventriculography
with coronary angiography was performed in all patients
older than 35 years of age with the exception of Patient 4,
who had a normal result on the treadmill test but did not
consent to angiography; the four patients tested (Cases 5,8,9
and II) had normal angiographic findings.
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Table 1. Clinical and Histologic Details in 12 Patients With Ventricular Arrhythmias Without Overt Cardiac Disease
Age (yr) Clinical Clinical Exercise
Case &Sex Presentation Arrhythmia Test Endomyocardial Biopsy
I 9F Syncope PSVT; VT (NS) PSVT Acute inflammatory myocarditis
2 29F Palpitation; VT (NS) VT Mild myocardial cellular hypertrophy
presyncope
3 32M Palpitation VT (NS) VT Moderate myocardial cellular
hypertrophy
4 56M VT on ET VT (NS) VT Focal myocardial degenerative
changes; mild increase in
interstitial cellularity
5* 45M Asymptomatic VT VT (NS) Complex Mild myocardial cellular hypertrophy
ectopic rhythm
6 15F Presyncope VT (NS) VT Mild focal interstitial fibrosis
7 29M Palpitation; None Not done Moderate myocardial cellular
presyncope hypertrophy; moderate interstitial
fibrosis; mild to moderate focal
endocardial fibrosis
8* 42F Palpitation; VT (S) Not done Moderate myocardial cellular
syncope hypertrophy; one microfocal patch
of interstitial fibrosis
9 57M Syncope VT (S) Not done Mild myocardial cellular
hypertrophy; mild to moderate
interstitial fibrosis
10 28F Presyncope; VT (S) Not done Mild to moderate interstitital fibrosis
palpitation
II 53M Palpitation; VT (S) Not done Moderate myocardial cellular
presyncope hypertrophy; moderate to marked
interstitial fibrosis; mild focal
endocardial fibrosis
12 2lF OHA (VF) VF Normal Normal
*Left ventricular endomyocardial biopsy. ET = exercise test; F = female; M = male; NS = nonsustained; OHA = out of hospital cardiac arrest;
PSVT = paroxysmal supraventricular tachycardia; S = sustained; VF = ventricular fibrillation; VT = ventricular tachycardia.
Electrophysiologic testing (Table 2). Electrophysiologic
testing was performed in 11 patients as described elsewhere
(McLaran CJ, Gersh BJ, Osborn MJ, et aI., unpublished
data). Antiarrhythmic medications were discontinued for at
least five drug half-lives before this study in 10 patients; in
1 patient, electrophysiologic testing was performed to assess
the efficacy of an antiarrhythmic medication already dem-
onstrated to be effective by 24 hour Holter monitoring.
Three multielectrode catheters were inserted percutaneously
through the right femoral vein and advanced to high in the
right atrium, to the atrioventricular (AV) junction and to
the right ventricular apex. Sinus node, AV node and His-
Purkinje function were evaluated in all patients. Stimulation
was performed with a Medtronic 5325 or 2335 custom stim-
ulator. Programmed ventricular stimulation was performed
at two sites in the right ventricle by using double or triple
extrastimuli introduced during sinus rhythm and at paced
cycle lengths of 600 and 400 ms and incremental burst
ventricular pacing (five beats) to 2:I capture or a cycle length
of 200 ms.
Programmed stimulation was performed in five of six
patients with nonsustained ventricular tachycardia observed
clinically. Of these five, ventricular tachycardia could be
induced in one (20%). Of the four patients with sustained
ventricular tachycardia observed clinically, programmed
ventricular stimulation induced ventricular tachycardia in
three; the fourth patient was studied while taking antiar-
rhythmic medications that prevented induction of the tachy-
cardia. Ventricular fibrillation- was induced in one patient
(Case 12) who had had it documented clinically at the time
of cardiac arrest. One patient with syncope but no clinically
documented arrhythmia had sustained ventricular tachy-
cardia induced at the time of electrophysiologic study. Ven-
tricular tachycardia was terminated in the electrophysiology
laboratory in two patients (Cases 9 and 12) by direct current
countershock (200 W/s).
Endomyocardial biopsy. Endomyocardial biopsy was
performed immediately before or after the electrophysio-
logic study or at the time of left ventricular angiography as
described previously (22). Three to seven biopsy specimens
(mean 4.5) were obtained from each patient. Each specimen
was evaluated by light microscopy by one of us (W.D.E.),
as described in detail earlier (22), and a mean number of
lymphocytes greater than 5.0 per high power field was con-
sidered to represent' active lymphocytic myocarditis. Myo-
cardial cellular hypertrophy was defined as an increase in
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Table 2. Results of Electrophysiologic Testing, Treatment and Follow-Up in 12 Patients With Ventricular Arrhythmias Without
Overt Cardiac Disease
Case
2
3
4
5
6
7
8
9
10
II
12
Programmed
Stimulation
a) AF, nonsustained;
b) VT (180 beats/min),
nonsustained
No inducible ventricular
arrhythmia
No inducible ventricular
arrhythmia; frequent
spontaneous nonsustained
VT with RBBB, LAD
configuration
Not studied
No inducible ventricular
arrhythmia
No inducible ventricular
arrhythmia
a) AF;
b) VT (150 beats/min),
LBBB configuration,
nonsustained
EP study while taking
mexiletine and
propranolol; no inducible
arrhythmia
VT (220 beats/min),
indeterminate
configuration, sustained
VT (155 beats/min), LBBB
configuration, sustained
VT (240 beats/min), LBBB
configuration, sustained
VF
Final Drug Treatment
Propranolol, 20 mg every 6 h;
tocainide, 200 mg every 8 h
Verapamil, 120 mg every 8 h
Propranolol, 60 mg every 6 h
Quinidine, 400 mg every 4 h;
propranolol, 20 mg every 8 h
Mexiletine, 200 mg every 8 h
Amiodarone, 200 mg daily
Propranolol, 60 mg every 6 h
Mexiletine, 200 mg every 6 h;
pindolol, 10 mg every 12 h
QUinidine, 300 mg every 6 h;
propranolol, 60 mg every 6 h
Pacemaker
Amiodarone, 400 mg daily
Atenolol, 100mg daily;
procainamide, I g every 6 h
Duration (mo)
44
3
2
3
12
2
Follow-Up
Symptomatic Status
Holter monitor, no arrhythmia; asymptomatic
Exercise test model, no arrhythmia;
asymptomatic
Exercise test model, no arrhythmia;
asymptomatic
Exercise test model, no arrhythmia;
asymptomatic
Failed to suppress VT; asymptomatic
Holter monitor, no arrhythmia; asymptomatic
EP restudy, no arrhythmia; asymptomatic
Holter monitor, one three-beat run of VT;
asymptomatic
EP restudy, no arrhythmia; asymptomatic
Asymptomatic
Holter monitor, no arrhythmia; asymptomatic
Asymptomatic
AF = atrial fibrillation; EP = electrophysiologic; LAD = left axis deviation; LBBB left bundle branch block; RBBB = right bundle branch
block; VF = ventricular fibrillation; VT = ventricular tachycardia.
cell diameter with certain characteristic nuclear changes (en-
largement, irregularity, hyperchromatic staining). Because
myocardial cellular hypertrophy may be nonuniform, the
degree of hypertrophy designated was an average of the
findings in the biopsy tissue.
Results
Histology. Histologic cardiac abnormalities were iden-
tified in 11 of 12 patients (Table 1). In only one patient
(Case 12) was the biopsy result normal. This patient had
had an out of hospital cardiac arrest and had inducible ven-
tricular fibrillation during electrophysiologic study. Biopsy
in the remaining 11 patients showed distinctly abnormal but
generally nonspecific features (Fig. 1). Although focal and
nonuniform, these abnormalities were generally found in all
biopsy specimens from an individual patient. The patient
with myocarditis (Case 1) has been described previously
(Case 7 in reference 23); however, further clinical follow-
up infortnation is given here.
Case 1. This patient was 6Y2 years old when first seen
because of syncope. No diagnosis was made and specific
treatment was not initiated at that time. During the ensuing
2Y2 years, she had recurrent syncopal spells; electrophysi-
ologic testing and endomyocardial biopsy were performed
at 9 years of age. Her electrocardiogram at rest was normal,
and nonsustained ventricular tachycardia had been docu-
mented clinically. Endomyocardial biopsy showed low grade
active inflammatory myocarditis. She was treated with cor-
ticosteroids for 8 months, and serial biopsies were per-
formed over a 33 month period. The final endomyocardial
biopsy, performed 24 months after corticosteroid therapy
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Figure 1. Case 1. Endomyocardial bi-
opsy specimen showing marked focal
interstitial fibrosis. (Hematoxylin-eosin;
X 250.)
had been discontinued, showed mild focal interstitial fibrosis
with no evidence of active myocarditis (Fig. 2). Despite the
resolution of the acute inflammatory changes, the patient
continued to require antiarrhythmic medication (tocainide)
for control of ventricular tachycardia associated with syn-
cope. Ventricular function remained normal at 44 months
after the initial diagnosis of active myocarditis.
Treatment and follow-up (Table 2). Eleven patients
were treated with one or more antiarrhythmic medications
and the remaining patient was treated with a custom-de-
signed antitachycardia pacing device. All patients were alive
and asymptomatic at a mean follow-up interval of 6 months.
Discussion
The majority of patients with ventricular tachycardia or
sudden cardiac arrest have underlying atherosclerotic coro-
nary artery disease (4,5) or cardiomyopathy (24). However,
a subgroup of patients without overt cardiac disease was
found in earlier studies of the etiology of ventricular tachy-
Figure 2. Case 11. Endomyocardial bi-
opsy specimen showing moderate inter-
stitial fibrosis and mild endocardial fi-
brosis. (Hematoxylin-eosin; x 250).
I
•
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cardia. Because many of these cases were reported before
angiocardiography and echocardiography were available, it
is conceivable that some of these patients had anatomic
abnormalities not detected by physical examination and chest
roentgenography. The recently described (25) entity of ar-
rhythmogenic right ventricular dysplasia may be especially
difficult to diagnose unless the patient is carefully evaluated
by two-dimensional echocardiography or right ventricular
angiography, or both (25). Despite the suspicion that in
some previous cases the diagnosis of idiopathic ventricular
tachycardia was a result of inadequate evaluation, in four
recent studies (16,17,19,20) with comprehensive cardiac
evaluation including echocardiography and angiography, there
remained a subgroup of patients with so-called "primary
electrical disease. "
Roleof underlying myocarditis. In our highly selected
group of 12 patients who had no anatomic basis for their
ventricular arrhythmia, all but 1 had an abnormal endo-
myocardial biopsy and 1 patient had clinically unsuspected
active lymphocytic myocarditis. Recognition of this is im-
portant because of the serious nature of the disease and the
potential for treatment (26). Life-threatening ventricular ar-
rhythmias complicating myocarditis may resolve after spe-
cific anti-inflammatory therapy (17). Thus, histologic ob-
servation may provide important prognostic information for
individual patients with serious ventricular arrhythmias.
Myocarditis may be more common than previously sus-
pected. In autopsy studies (27-29), focal myocardial in-
flammatory changes have been found in I to 5% of patients
dying a sudden accidental death or a sudden unexpected
death. Although active myocarditis is usually associated
with some abnormalities in ventricular function (30,31) and
on the electrocardiogram at rest (32), the results of this and
previous studies (30,31,33) demonstrate that both ventric-
ular function and the surface electrocardiogram may be nor-
mal despite histologic evidence of its presence. Definitive
diagnosis of this condition can only be established by en-
domyocardial biopsy.
Significance of endomyocardial biopsy findings. The
majority of patients in this series had distinctly abnormal
but nonspecific biopsy findings; the significance of these
findings is unclear at present. Although direct current coun-
tershock can cause myocardial necrosis (34), this is unlikely
to be the cause of the histologic abnormalities in our pa-
tients. Only two of our patients had direct current shock
before endomyocardial biopsy; in one, the histologic find-
ings were normal and in the other, the abnormalities rep-
resented a chronic process. Van Hoogenhuyze et al. (33)
suggested that these findings may be compatible with the
diagnosis of early dilated cardiomyopathy, but in the pres-
ence of normal ventricular function this does not seem to
be a valid conclusion because of the nonspecificity of the
histologic abnormalities (35,36). The results of follow-up
biopsy in our patient with healed myocarditis were indis-
tinguishable from those in the other patients in this study.
Although it is possible that some of these other patients may
have had previous myocarditis that had resolved, this cannot
be proved. Furthermore, the association of ventricular ar-
rhythmias with histopathologic abnormalities does not es-
tablish a causal relation.
Role of electrophysiologic testing. Because of the low
tachycardia induction rate in patients without overt cardiac
anatomic abnormalities who have nonsustained ventricular
tachycardia, the role of electrophysiologic testing remains
to be determined. The results of programmed ventricular
stimulation in this study are similar to those described by
Naccarelli et al. (20), who induced ventricular tachycardia
in 100% of patients with sustained ventricular tachycardia
but in only 32% of patients in whom the tachycardia was
clinically nonsustained. Nevertheless, because of the life-
threatening nature of the arrhythmias, the identification of
an effective drug regimen by using programmed ventricular
stimulation is an attractive approach to therapy.
Clinical implications. Does endomyocardial biopsy al-
ter management in these patients? At present. it is of major
help only in those patients presenting with severe ventricular
arrhythmias as the sole manifestation of acute myocarditis.
Its utility in the majority of patients is uncertain. Long-
term follow-up, however, may show that the presence of
histologic abnormalities in patients with otherwise normal
ventricular function has prognostic implications. On the ba-
sis of this study. we conclude that the majority of patients
with ventricular tachycardia and normal cardiac mechanical
function indeed have abnormal myocardium. Consequently,
we question the validity of the concept of "idiopathic ven-
tricular tachycardia" or "primary electrical disease."
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